Rapid Antigen tests advised only for symptomatic people, immediate contacts of Covid positive patients: ICMR

New Delhi : The Indian Council of Medical Research (ICMR) on Wednesday said that only symptomatic individuals and immediate contacts of Covid-19 positive patients are advised for home testing by Rapid Antigen Tests (RAT).

“Home testing by RAT is advised only in symptomatic individuals and immediate contacts of laboratory-confirmed positive cases. Indiscriminate testing is not advised. Home testing should be conducted as per the procedure described by the manufacturer in the user manual (pictorial and video link of the user manual is provided below against the name of the approved test kit),” reads the ICMR advisory.

ICMR suggests users to download the home testing mobile app on their smartphones and said the app is a comprehensive guide of the testing procedure and will provide a positive or negative test result to the patient.

“All users are advised to click a picture of the test strip after completing the test procedure with the same mobile phone which has been used for downloading the mobile app and user registration. Data in the app of your mobile phone will be centrally captured in a secure server that is connected with the ICMR Covid-19 testing portal, where all data will be eventually stored. Patient confidentiality will be fully maintained. All individuals who test positive may be considered as true positives and no-repeat testing is required,” ICMR said.

The Council further said symptomatic individuals who test negative by RAT should get themselves immediately tested by RTPCR. “This is especially important as the RATs are likely to miss few positive cases presenting with a low viral load. All RAT negative symptomatic individuals may be treated as suspect Covid-19 cases,” it added.

ICMR informed CoviSelf (PathoCatch) Covid-19 OTC Antigen LF device manufactured by Pune-based Mylab Discovery Solutions Ltd has been validated and approved. (ANI)

  • Related Posts

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    India’s $30-billion pharma industry is staring at a fresh challenge after US President Donald Trump announced that generic medicines imported into the US would face tariffs of 100% from Aug…

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    New Delhi: A joint operation by the Delhi Police Crime Branch, the Central Drugs Standard Control Organisation (CDSCO) and the Gautam Buddha Nagar District Drug Department uncovered a suspected illegal…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    Fake Medicines Worth Over Rs 5 Crore Seized From Factory In Uttarakhand’s Dehradun

    Fake Medicines Worth Over Rs 5 Crore Seized From Factory In Uttarakhand’s Dehradun

    A ‘Fatal Flaw’ might be lurking in apparently Healthy Heart- Dr Devi Shetty

    A ‘Fatal Flaw’ might be lurking in apparently Healthy Heart- Dr Devi Shetty

    CDSCO declares 159 drug samples as NSQs in June

    CDSCO declares 159 drug samples as NSQs in June